Increasing Diversity in Clinical Trials Expert Meeting

OCTOBER 12 & 21, 2021

CTTI Project: Diversity

Meeting Objectives:

Present findings from project evidence generation: in-depth interviews with key decision-makers.
Refine a maturity model for organizational-level strategies to increase diversity in clinical trials.
Identify specific multi-stakeholder, portfolio-level strategies to increase the participation of underrepresented racial and ethnic minorities and women in clinical trials.

Meeting Location: Virtual Meeting

Meeting Summary

Meeting Agenda

List of Meeting Attendees

Pre-Meeting Materials

Meeting Materials:

Day 1

Welcome and Introduction
Session I: Review of In-Depth Interview Findings
Session II: Organizational Strategies to Increase Diversity in Clinical Trials - Yale
Session III: Diversity Maturity Model Breakout Discussions
Mentimeter Results

Day 2

Session IV: Welcome & Representation in U.S. Clinical Trials
- Part I: RADM Richardae Araojo, FDA Office of Minority Health and Health Equity
- Part II: Kaveeta Vasisht, FDA Office of Women’s Health
Session V: Review of Day 1 and Maturity Model
Session VI: Diversity Maturity Model Breakout Discussions
Mentimeter Results

The views and opinions expressed in this presentation are those of the individual presenter and should not be attributed to the Clinical Trials Transformation Initiative, or any organization with which the presenter is employed or affiliated.